Moore Rustin M, Sedrish Steven A, Holmes Earnestine P, Koch Catherine E, Venugopal Changaram S
Equine Health Studies Program, Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
Can J Vet Res. 2005 Apr;69(2):116-22.
The objective of this study was to determine and compare the in vitro responses of equine large colon arterial and venous rings to vasodilatory neuropeptides; calcitonin gene-related peptide (CGRP); substance P (SP); vasoactive intestinal polypeptide (VIP); and acetylcholine (ACh), a standard nonpeptide endothelium-dependent vasodilator. Responses of vessel rings to graded concentrations (10(-11) M to 10(-5) M) of each drug were determined in endothelium-intact, denuded, and Nomega-nitro-L-arginine methyl ester (L-NAME, 10(-5) M)-treated rings that were pre-contracted with norepinephrine. Percentage maximal relaxation (PMR), defined as the % decrease from the contracted state, was determined. Because all rings did not relax at least 50%, EC50 values could not be consistently calculated. Arterial rings with intact endothelium were more sensitive to CGRP, compared with VIP and SP, and venous rings of all conditions were more sensitive to VIP than CGRP or SP. Overall, arteries had a greater PMR for ACh compared with SP and VIP. Intact and L-NAME treated arteries had a greater PMR than denuded arteries; there were no differences in PMR of intact and L-NAME treated arteries. Veins had a greater PMR for VIP than CGRP, SP, or ACh. Calcitonin gene-related peptide caused greater relaxation in intact arteries, whereas VIP causes greater relaxation in veins. Arterial relaxation was dependent upon the presence of intact endothelium. The response of veins to VIP among the conditions tested was not different, suggesting VIP has direct actions on venous smooth muscle. These neuropeptides modulate vasomotor tone via vasorelaxation in colonic arteries and veins.
本研究的目的是测定并比较马的大结肠动脉环和静脉环对血管舒张性神经肽;降钙素基因相关肽(CGRP);P物质(SP);血管活性肠肽(VIP);以及乙酰胆碱(ACh,一种标准的非肽类内皮依赖性血管舒张剂)的体外反应。在预先用去甲肾上腺素预收缩的内皮完整、去内皮和用Nω-硝基-L-精氨酸甲酯(L-NAME,10⁻⁵ M)处理的血管环中,测定血管环对每种药物的分级浓度(10⁻¹¹ M至10⁻⁵ M)的反应。确定最大舒张百分比(PMR),定义为从收缩状态下降的百分比。由于并非所有血管环都至少舒张50%,因此无法一致地计算出半数有效浓度(EC50)值。与VIP和SP相比,内皮完整的动脉环对CGRP更敏感,并且所有条件下的静脉环对VIP比对CGRP或SP更敏感。总体而言,与SP和VIP相比,动脉对ACh的PMR更大。完整和L-NAME处理的动脉的PMR比去内皮的动脉更大;完整和L-NAME处理的动脉的PMR没有差异。静脉对VIP的PMR比对CGRP、SP或ACh更大。降钙素基因相关肽在完整动脉中引起更大的舒张,而VIP在静脉中引起更大的舒张。动脉舒张依赖于完整内皮的存在。在所测试的条件下,静脉对VIP的反应没有差异,表明VIP对静脉平滑肌有直接作用。这些神经肽通过结肠动脉和静脉的血管舒张来调节血管运动张力。